Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who had cancer more than 5 years ago and received chemotherapy and/or radiation treatment that may have affected the heart (this mainly includes survivors of breast cancer, Hodgkin's lymphoma, and prostate cancer)
Who may not be able to join:
- People who are unable to give written consent to take part in the study
- People who have been diagnosed with coronary artery disease (a condition affecting the blood vessels of the heart) at the time of joining the trial
- People who have a history of coronary artery disease at any point in the past
- People for whom clear CT scan images cannot be obtained
- People who have a medical reason preventing them from taking statins (a type of cholesterol-lowering medication), cannot tolerate them, or who are already taking them
- People whose cancer or another serious health condition (including pregnancy) means the trial doctors believe it would not be appropriate for them to participate, or whose life expectancy is less than 12 months for any reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tom Marwick, MBBS,PhD,MPH, Baker Heart and Diabetes Institute
Phone: +61 3 8532 1550
Australian sites
0362268816
+61385321624
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Proportion of evaluated patients who should undergo CAD prevention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.